Large-scale studies to calculate the incidence of CSF3R mutations in AML and ALL showed that these are not common mutations but are often associated with genetic alterations in core-binding factor gene abnormalities [19]. This evidence concerns the gene CSF3R and acute lymphoblastic leukemia.